Related Experiment Video
Updated: Jul 31, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Decrease in Pneumococcal Otitis Media Cultures With Concomitant Increased Antibiotic Susceptibility in the
Basel Jabarin1, Jacob Pitaro, Tzilia Lazarovitch
1*Department of Otolaryngology-Head and Neck Surgery †Clinical Microbiology Laboratory, Assaf Harofeh Medical Center, Tel Aviv University Sackler School of Medicine, Zerifin, Israel.
Objective:
To study the change in the incidence and antibiotic susceptibility patterns of Streptococcus pneumoniae (Spn) in cultures obtained from children with otitis media (OM) during the pneumococcal conjugate vaccines (PCVs) era.
Study Design:
Retrospective.
Setting:
Secondary medical care center.
Patients:
Children less than 8 years who presented with OM and had positive pneumococcal cultures during January 1, 2007 to December 12, 2014 were identified. Data recorded included demographics, preadmission antibiotics, culture source, and antibiotic susceptibility tests. We compared the pre-PCV years (2007-2008) with the transition years (2009-2011) and the post-PCV13 years (2012-2014).
Interventions:
PCV7 (2009), PCV13 (2010), therapeutic.
Main Outcome Measure(S):
Annual rate of Spn cultures, antibiotic susceptibility patterns.
Results:
We identified 134 children (76 boys, 57%) who contributed 162 pneumococcal cultures. There was a downward trend in the annual incidence rate of Spn cultures between the pre-PCV years, transition years, and post-PCV13 years: 11.12, 8.48, and 4.11/1000 hospitalized children/year, respectively (p = 0.08, p = 0.04). Had there been no interventions, and based on the 2007 to 2009 average, the observed over the expected Spn cultures ratio rates for 2010 to 2014 were 0.59, 0.45, 0.40, 0.40, and 0.25, respectively. In parallel, the susceptibility of Spn strains to four commonly tested antibiotics significantly increased from the pre-PCV years to the transition years and the post-PCV13 years. In each period, Spn strains were penicillin sensitive in 37, 51, and 100%; for erythromycin, 46, 71, and 82%; for trimethoprim/sulfamethoxazole, 32, 71, and 97%; and for ceftriaxone, 95, 96, and 100%, respectively.
Conclusion:
The introduction of PCVs significantly decreased the incidence rate of pneumococcal OM, and increased Spn susceptibility to common antibiotics.
Insights
Pneumococcal conjugate vaccines (PCVs) significantly reduced Streptococcus pneumoniae (Spn) incidence in children with otitis media. Spn also showed increased susceptibility to common antibiotics following PCV introduction.
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Microbiology
Background:
- Otitis media (OM) is a common childhood infection.
- Streptococcus pneumoniae (Spn) is a primary cause of OM.
- The advent of pneumococcal conjugate vaccines (PCVs) aimed to reduce Spn-related diseases.
Purpose of the Study:
- To evaluate the impact of PCVs on the incidence of Spn in pediatric OM.
- To assess changes in antibiotic susceptibility patterns of Spn isolates during the PCV era.
Main Methods:
- Retrospective study of children under 8 with OM and positive Spn cultures (2007-2014).
- Comparison of Spn incidence and antibiotic susceptibility across pre-PCV, transition, and post-PCV13 periods.
- Analysis of culture data, demographics, and antibiotic susceptibility testing.
Main Results:
- A significant downward trend in Spn incidence was observed post-PCV introduction.
- Spn susceptibility to penicillin, erythromycin, trimethoprim/sulfamethoxazole, and ceftriaxone increased significantly over time.
- The ratio of observed to expected Spn cultures decreased substantially after PCV implementation.
Conclusions:
- PCVs effectively reduced the incidence of Spn-causing OM in children.
- Vaccination with PCVs correlated with improved antibiotic susceptibility in circulating Spn strains.
- These findings underscore the public health impact of PCV vaccination programs.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Antimicrobial Effectiveness
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction